Insider Transactions in Q3 2023 at Spero Therapeutics, Inc. (SPRO)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2023
|
Kamal Hamed Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,496
-6.41%
|
$39,496
$1.27 P/Share
|
|
Aug 29
2023
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
4,163
-0.72%
|
$4,163
$1.3 P/Share
|
|
Aug 28
2023
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
1,854
-0.32%
|
$1,854
$1.26 P/Share
|
|
Aug 28
2023
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
9,040
-1.13%
|
$9,040
$1.26 P/Share
|
|
Aug 28
2023
|
Tamara L Joseph Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,854
-0.57%
|
$1,854
$1.26 P/Share
|
|
Aug 28
2023
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,854
-0.57%
|
$1,854
$1.26 P/Share
|
|
Aug 01
2023
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
266,000
+31.5%
|
-
|